Michael A. Klufas, M.D.
Fellowship: Jules Stein Eye Institute, UCLA
Residency: New York Presbyterian Hospital, Weil Cornell
Medical School: Weill Cornell Medical College
Undergraduate: Brown University
Dr. Michael Klufas graduated Magna Cum Laude with Honors in Neuroscience from Brown University, and received his Doctor of Medicine degree with academic distinction and Honors in Research from Weill Cornell Medical College, New York, NY. Dr Klufas completed his transitional intern year at Memorial Sloan-Kettering Cancer Center in New York, NY. He performed his ophthalmology residency at New York Presbyterian Hospital/Weill Cornell, New York, NY where he was awarded the Weill Cornell Resident Research Award and the New York Weill Cornell Medical Center Alumni Council Distinguished Housestaff Award. Dr Klufas completed his two-year vitreoretinal surgery fellowship at Jules Stein Eye Institute/University of California, Los Angeles, CA where he was recognized as the Thelma and William Brand Fellow & Abe Meyer Memorial Fellow, and received the Stein Eye Institute Fellow Teaching Award.
Dr. Klufas is Board Certified in Ophthalmology. He is an active member of the Retina Service at Wills Eye Hospital, and is an Assistant Professor of Ophthalmology at Sidney Kimmel Medical College of Thomas Jefferson University.
Dr. Klufas is a member of the American Academy of Ophthalmology, American Society of Retina Specialists, and Association for Research in Vision and Ophthalmology. He has authored numerous scientific publications and textbook chapters on vitreoretinal diseases, and has been an invited speaker to present scientific papers and abstracts at national ophthalmic meetings. He is actively involved as a clinical investigator in several collaborative trials and studies on various conditions including age-related macular degeneration, diabetic retinopathy, retinal vein occlusion and inherited retinal degenerations. He also serves as a manuscript reviewer for a number of distinguished ophthalmic journals.
Dr. Klufas' areas of interest include advanced treatments for age-related macular degeneration, retinal imaging, clinical trials, pediatric vitreoretinal disorders including retinopathy of prematurity and innovative vitreoretinal surgical techniques and device development.